Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Spiridonidis

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Lung Cancer|January 17, 2004
Docetaxel and gemcitabine combinations in chemotherapy-pretreated non small-cell lung cancerC H Spiridonidis, L R Laufman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung cancer: a phase II trial of a novel scheduleC H Spiridonidis, L R Laufman, J J Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignanciesC H Spiridonidis, L R Laufman, J Jones, et al.
American Journal of Clinical Oncology|December 1, 1995
Phase II evaluation of low-dose continuous 5-fluorouracil and weekly cisplatin in advanced adenocarcinoma of the stomach. A Southwest Oncology Group studyS K Williamson, C M Tangen, A M Maddox, et al.
American Journal of Clinical Oncology|August 1, 1993
Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group studyE H Kraut, T Fleming, J S Macdonald, et al.
Cancer|November 15, 1996
A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinomaC H Spiridonidis, L R Laufman, J J Jones, et al.
American Journal of Clinical Oncology|June 17, 1998
CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trialA Sandler, C Blanke, F Monaco, et al.
Investigational New Drugs|January 1, 1996
A phase II study of weekly oral methotrexate and zidovudine (AZT) in advanced adenocarcinoma of the pancreas and hepatocellular carcinomaK D Miller, P J Loehrer, R Gonin, et al.
Seminars in Oncology|December 10, 1999
Docetaxel and gemcitabine combinations in non-small cell lung cancerN A Rizvi, C H Spiridonidis, T H Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trialC H Spiridonidis, L R Laufman, L Carman, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Lung Cancer|January 17, 2004
Docetaxel and gemcitabine combinations in chemotherapy-pretreated non small-cell lung cancerC H Spiridonidis, L R Laufman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung cancer: a phase II trial of a novel scheduleC H Spiridonidis, L R Laufman, J J Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignanciesC H Spiridonidis, L R Laufman, J Jones, et al.
American Journal of Clinical Oncology|December 1, 1995
Phase II evaluation of low-dose continuous 5-fluorouracil and weekly cisplatin in advanced adenocarcinoma of the stomach. A Southwest Oncology Group studyS K Williamson, C M Tangen, A M Maddox, et al.
American Journal of Clinical Oncology|August 1, 1993
Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group studyE H Kraut, T Fleming, J S Macdonald, et al.
Cancer|November 15, 1996
A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinomaC H Spiridonidis, L R Laufman, J J Jones, et al.
American Journal of Clinical Oncology|June 17, 1998
CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trialA Sandler, C Blanke, F Monaco, et al.
Investigational New Drugs|January 1, 1996
A phase II study of weekly oral methotrexate and zidovudine (AZT) in advanced adenocarcinoma of the pancreas and hepatocellular carcinomaK D Miller, P J Loehrer, R Gonin, et al.
Seminars in Oncology|December 10, 1999
Docetaxel and gemcitabine combinations in non-small cell lung cancerN A Rizvi, C H Spiridonidis, T H Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trialC H Spiridonidis, L R Laufman, L Carman, et al.
Pageof 2